C-反应蛋白的10大临床应用,看看哪些你不知道!

2018-01-02 医考君 医考之声

一、CRP是啥? C-反应蛋白(CRP)是机体受到微生物入侵或组织损伤等炎症性刺激时肝细胞合成的一种急性相蛋白,它是高度灵敏的炎症指标。CRP在健康人血清中浓度很低,而在细菌感染或组织损伤时,其浓度显著(10倍甚至百倍)升高,而且上升和下降都很迅速。


一、CRP是啥?

C-反应蛋白(CRP)是机体受到微生物入侵或组织损伤等炎症性刺激时肝细胞合成的一种急性相蛋白,它是高度灵敏的炎症指标。CRP在健康人血清中浓度很低,而在细菌感染或组织损伤时,其浓度显著(10倍甚至百倍)升高,而且上升和下降都很迅速。

当健康人没有细菌感染时,C-反应蛋白在5-10mg/L认为是在参考范围内。然而现已证实,正常人的C-反应蛋白参考范围是小于/等于lmg/L。

二、CRP与hsCRP有啥区别?

其实这两者检测血中相同的物质—CRP,只是是检测方法和范围的差异。常规的CRP最低检测限 < 3mg/L,而超敏C反应蛋白(hsCRP)检测则可准确给出从0.15-8.0mg/L定量值。这个称作为超敏C反应蛋白或高灵敏度CRP(hsCRP)。

hsCRP :准确的检测低水平的CRP和微小变化、更为更敏感。主要用于诊断和预测心血管事件的发生、发展。

常规CRP:它在低水平区灵敏度较差,主要用于细菌感染、各种炎症过程、组织坏死与组织损伤及其恢复期的筛检、监测、病情评估与疗效判断。

三、CRP能反应啥?

1、急性或慢性炎症如伴有细菌感染
2、器质性疾病的筛选
3、自身免疫免疫复合物病
4、组织坏死和恶性肿瘤

四、 CRP的临床应用

1、感染的诊断与鉴别

当发生各种感染性疾病时,其组织损伤物质及炎症物质大量进入血液循环,通过相应的细胞因子介导刺激肝脏合成CRP,导致机体反应的CRP升高。细菌的内毒素是急性时相反应的最有效的刺激,所以最高水平的CRP可发生在革兰阴性菌感染,有时高达500 mg/L。

但病毒不具有完整的细胞结构,CRP不能与之结合,所以病毒感染时一般轻度或不升高。但腺病毒及某些疱疹病毒可造成较大的组织损伤使得C-反应蛋白轻度增高。

CRP在细菌感染发生后4~6小时即开始升高,36~48小时达到高峰,因为CRP半衰期只有4 - 7小时,所以在感染控制后其含量急骤下降,3-7天内可恢复正常。

病毒感染:一般低于10 mg/L ,通常不超过50 mg/L。
细菌感染:CRP含量一般高于20 mg/L。
革兰阴性菌感染:可高达500 mg/L。
革兰阳性菌感染、寄生虫感染:通常引起中等程度的反应,典型的是在100 mg/L左右。

CRP为急性时相反应蛋白,在感染时反应速度快,与WBC感染指标相比,CRP更加敏感。而且CRP不受生理,免疫状态,药物治疗等影响。所以CRP为鉴别细菌感染与病毒感染的首选指标。可在感染早期可靠地判断究竟是细菌感染还是病毒感染,以决定是否进行抗生素治疗。

2、抗生素的治疗监测

CRP是评价抗生素治疗效果的独立指标,可以很好地用来检测急性细菌感染及判定抗生素疗效,在粒细胞缺乏或作免疫抑制疗法时尤为适用。对抗生素治疗患者,在抗生素治疗前和治疗后24h、治疗结束前各作常规检测一次。对抗菌治疗有良好反应的患者,其CRP值的下降非常迅速,通常24小时可以下降一半。CRP下降至正常时,中断抗生素治疗。

3、预测将来心肌梗塞与中风的危险性

CRP是心血管疾病最强的危险指标,美国疾病控制预防中心建议其用于心血管疾病预防筛选指标,可预测将来急性心梗及中风的危险性。

低度风险:<1mg mg/L
中度风险1-3 mg/L
高度风险3-10 mg/L
大于10 mg/L,可能存在感染,应治疗后复查。

CRP含量>2.1mg/L的人与<1mg/L者比较:将来发生心肌梗塞的危险性为后者的2.9倍;发生缺血性中风的危险性为后者的1.9倍;发生外周动脉血管性疾病的危险性为后者的4.1倍。

4、用于自身免疫性疾病

SLE、多肌炎、混合性结缔组织病、溃疡性结肠炎,CRP轻度升高或不升高。如果SLE患者CRP显著升高强烈提示并发了细菌感染,而与病情活动程度无关。而类风湿关节炎患者CRP水平与疾病的严重程度、关节的咬合程度及受累关节数相关。

5、恶性肿瘤

恶性肿瘤患者CRP大都升高。如CRP与AFP的联合检测,可用于肝癌与肝脏良性疾病的鉴别诊断。CRP测定用于肿瘤的治疗和预后有积极意义,手术前CRP上升,手术后则下降。且其反应不受放疗、化疗和皮质激素治疗的影响,有助于临床估价肿瘤的进程。 

6、外科疾病

手术:患者施行手术后24~72h血中CRP水平明显升高,约在第5~7天恢复正常。凡骤升后持续高水平甚至增高,应怀疑合并感染。对中、大手术患者,在术前和术后3~7天各作常规检测一次。

急性阑尾炎:急性阑尾炎的诊断常基于医生对临床症状的检查,误诊率不低,未穿孔者CRP轻度增高,在20mg/L以上。约15% - 25%阑尾穿孔病人CRP常超过100mg/L。如WBC和CRP均正常,则急性阑尾炎的可能性不大。CRP>100mg/L提示可能穿孔。

7、内科疾病

肺炎:对疑似肺炎者,C-反应蛋白被认为是筛查的第一线检查方法。CRP大于60mg/L常提示为细菌性肺炎。

急性支气管炎:很少源于细菌感染,也很少导致C-反应蛋白显著升高。所以CRP测定可以帮助鉴别肺炎和支气管炎。

急性心梗:急性心梗时CRP升高,在无溶栓治疗时与梗死范围呈正相关。在与梗塞有关的冠状动脉完全堵塞时CRP更高。
广泛梗死时C-反应蛋白平均160mg/L。
局部梗死时C-反应蛋白平均60mg/L。

8、妇产科疾病

盆腔炎和子宫附件炎,CRP值升高。
盆腔肿块和子宫肌瘤通常多为阴性。

9、儿科感染性疾病与老年患者

CRP在儿科感染疾病应用的分界值为<10mg/L,新生儿感染分界值为2mg/L,大于32mg/L常提示感染。如不是新生儿,病程大于6-12小时,CRP<10mg/L可基本排除细菌感染或细菌已被清除。若>25mg/L常提示细菌感染。 

老年人可能有感染较早却无发热、白细胞升高等情况,这时测C-反应蛋白有助于检出细菌感染。

10、白血病患者并发感染

急性白血病患者合并感染的早期,中性粒细胞减低而诊断困难。所以这时候连续监测CRP对发现隐蔽性的细菌感染是一种非常有效的帅选试验。若CRP 显著升高(>100mg/L)提示白血病患者合并感染,应及早使用抗生素。

最后需要说明的是,CRP是非特异性指标,在临床实际工作中要注意结合病史、症状、体征和其他辅助检查结果,综合分析病情。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-04 186****0580(小山羊)

    学习了谢谢了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-04 孙文杰

    不错不错学习了.但是还有急性胰腺炎呢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-03 haige

    够详细!学习了!谢谢!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-03 李香香

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-02 惠映实验室

    学习了.谢谢.

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1835729, encodeId=452d1835e2948, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Thu Mar 22 05:44:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275326, encodeId=dea72e532624, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Thu Jan 04 09:31:14 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1575044, encodeId=5f1915e5044ee, content=<a href='/topic/show?id=b265388684' target=_blank style='color:#2F92EE;'>#C-反应蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3886, encryptionId=b265388684, topicName=C-反应蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab8416056084, createdName=szhvet, createdTime=Thu Jan 04 07:44:00 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275289, encodeId=85462e528910, content=不错不错学习了.但是还有急性胰腺炎呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/y1ZJaAFo7AFqm7Hn2QNVTjOpBV9mRicUEjyBqRMnLADF1oQXJGeIVCpiaY1hJVMd1C40EhFCw4LL8sCKTx8Yuvsw/132, createdBy=af0b1960284, createdName=孙文杰, createdTime=Thu Jan 04 07:30:29 CST 2018, time=2018-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275127, encodeId=a2122e5127f2, content=够详细!学习了!谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdgSW0vVibEHQRlKXLlvMibvcHmy5ibwM7Luib2am6ywX6FqBrXibF8k7JVEzriaOSghltmYz1nomRd6TgSp2Yj9xHGAY/0, createdBy=9b2f2045808, createdName=haige, createdTime=Wed Jan 03 20:31:38 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=275056, encodeId=e4c62e5056c8, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/19/65b621d4a385e517982f632daf4124bb.jpg, createdBy=93302217036, createdName=李香香, createdTime=Wed Jan 03 12:21:20 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274872, encodeId=72f82e4872ef, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Jan 02 23:31:50 CST 2018, time=2018-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274805, encodeId=fecd2e4805e1, content=学习了受益匪浅, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Tue Jan 02 18:27:10 CST 2018, time=2018-01-02, status=1, ipAttribution=)]
    2018-01-02 131****1460

    学习了受益匪浅

    0

相关资讯

JACC:肥胖者CRP与动脉粥样硬化不相关

  研究人员发现,当体重指数(BMI)增加时,C-反应蛋白(CRP)与多种反应动脉粥样硬化的指标之间的关系被削弱了。   根据美国达拉斯市的德克萨斯大学西南医学中心的Amit Khera及其同事们的研究,对于正常体重或超重男性(P=0.001andP<0.0001,分别)以及正常体重女性(P=0.005),他们体内高敏感度CRP水平的升高与冠状动脉钙化相关,然而在无论男女的肥胖个体,却不存

C–反应蛋白临床意义

CRP是机体受到微生物入侵或组织损伤等炎症性刺激时肝细胞合成的急性相蛋白。

J Clin Periodontol:牙周病可增加女性患心血管疾病的风险

J Clin Periodontol:牙周病可增加女性患心血管疾病的风险关键词:心血管疾病 C-反应蛋白 糖尿病 MI家族史 牙周病 吸烟过去几十年积累的证据表明,牙周病与未来患心血管疾病之间具有显著地相关关系。然而,由于先前的研究在患病过程都包含了较多的变量,使得患病率研究变得有限。相反,分析前瞻性观察研究中的疾病发生,通常能提供更好的暴露程度,因此能更准确的评估风险。关于牙周治疗对心血管疾病

Omega-3脂肪酸或可降低HIV患者心血管疾病的发病风险

据IDWeek 2016上一项新的研究展示表明,与安慰剂相比,接受抗逆转录病毒治疗稳定的HIV患者每日摄入较高水平的Omega-3脂肪酸可显著降低甘油三酯和C-反应蛋白的水平。HIV患者是心血管疾病的高危患者,该研究中,研究人员进行了一项随机对照试验以探究高剂量的ω-3脂肪酸在HIV患者中对血脂、炎症和血管功能的长期作用。研究共纳入了117名HIV感染者,均接受抗逆转录病毒治疗。随机分配分别每天接

Am J Kidney Dis:C-反应蛋白可预测终末期肾病风险

伴有贫血和CKD的2型糖尿病患者CRP基础水平升高很是常见,并且与将来发展为终末期肾病以及死亡或终末期肾病的复合结局相关。